Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cofactors in reactions during maintenance after milk and egg oral immunotherapy
2018-002225-26Phase 4Active
- Sponsor
- Hospital Universitario Fundación Alcorcón
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin in cow's milk protein allergy (CMPA) and egg allergy, sponsored by Hospital Universitario Fundación Alcorcón. Primary endpoint: Tolerance to exercise or NSAID intake after food ingestion. Started Jun 2019; status: active.
02
Drugs
aspirin
03
Conditions
cow's milk protein allergy (CMPA)egg allergy
Beyond the preview
Go deeper on 2018-002225-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002225-26.